In this study, patients received 10 tDCS sessions (five times/week for 2 weeks: 10 sessions). The participants were assessed with the CERAD-K neuropsychological battery and underwent resting-state fMRI within 2 weeks before the first tDCS session and after the 10 th session. Subjects underwent [18 F] flutemetamol (FMM) positron emission tomography‒computed tomography (PET-CT) and APOE genotyping within 4 weeks before the first tDCS session. In addition, participants and the psychologists who performed the neuropsychological battery were blinded to the results of amyloid-PET and APOE genotyping.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.